Common use of Purchase and Sale of the Purchased Assets Clause in Contracts

Purchase and Sale of the Purchased Assets. Section 2.1 Purchase and Sale 10 Section 2.2 Purchase Price 11 Section 2.3 No Assumed Obligations 12 Section 2.4 Excluded Assets 12 ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE SELLER Section 3.1 Organization 12 Section 3.2 No Conflicts 12 Section 3.3 Authorization 13 Section 3.4 Ownership 13 Section 3.5 Governmental and Third Party Authorizations 14 Section 3.6 No Litigation 14 Section 3.7 Solvency 14 Section 3.8 Tax Matters 15 Section 3.9 No Brokers’ Fees 15 Section 3.10 Employee Benefit Matters 15 Section 3.11 Compliance with Laws 15 Section 3.12 Licensed Products 16 Section 3.13 Regulatory Approval 16 Section 3.14 Counterparty Agreement 17 Section 3.15 First Agreement and Second Agreement 19 Section 3.16 UCC Matters 20 Section 3.17 Margin Stock 20 Section 3.18 Investment Company Act 20 ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE PURCHASER Section 4.1 Organization 20 Section 4.2 No Conflicts 21 Section 4.3 Authorization 21 Section 4.4 Governmental and Third Party Authorizations 21 Section 4.5 No Litigation 21 Section 4.6 Access to Information 22 Section 4.7 No Competitor 22 Section 4.8 UCC Matters 22 ARTICLE V COVENANTS

Purchase and Sale of the Purchased Assets. Section 2.1 Purchase and Sale 10 11 Section 2.2 Entitlement to Payments 12 Section 2.3 Purchase Price 11 12 Section 2.3 2.4 No Assumed Obligations 12 Section 2.4 2.5 Excluded Assets 12 13 ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE SELLER Section 3.1 Organization 12 13 Section 3.2 No Conflicts 12 Section 3.3 Seller Authorization 13 Section 3.4 Ownership 13 Section 3.5 3.3 Governmental and Third Party Authorizations 13 Section 3.4 Ownership 14 Section 3.5 Solvency 14 Section 3.6 No Litigation 14 Section 3.7 Solvency 14 Section 3.8 Tax Matters 15 Section 3.9 No Brokers’ Fees 15 Section 3.10 Employee Benefit Matters 15 Section 3.11 Compliance with Laws 15 Section 3.12 Licensed Products 3.8 No Conflicts 15 Section 3.9 Intellectual Property Rights 16 Section 3.10 Regulatory Approval, Manufacturing and Marketing 18 Section 3.11 No Subordination 18 Section 3.12 Counterparty License Agreement and UAB Agreement. 18 Section 3.13 Regulatory Approval 16 Set-off and Other Sources of Royalty Reduction 20 Section 3.14 Counterparty Agreement 17 UCC Matters 20 Section 3.15 First Agreement and Second Agreement 19 Tax Matters 20 Section 3.16 UCC Matters UAB Agreement 20 Section 3.17 Margin Stock 20 21 Section 3.18 Investment Company Act 20 ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE PURCHASER Section 4.1 Organization 20 Section 4.2 No Conflicts 21 Section 4.3 Authorization 21 Section 4.4 Governmental and Third Party Authorizations 21 Section 4.5 No Litigation 21 Section 4.6 Access to Information 22 Section 4.7 No Competitor 22 Section 4.8 UCC Matters 22 ARTICLE V COVENANTSDisclosure 21

Purchase and Sale of the Purchased Assets. Section 2.1 Purchase and Sale 10 11 Section 2.2 Purchase Price 11 12 Section 2.3 No Assumed Obligations 12 Section 2.4 Excluded Assets 12 13 Section 2.5 Power of Attorney 13 ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE SELLER Section 3.1 Organization 12 14 Section 3.2 No Conflicts 12 14 Section 3.3 Authorization 13 15 Section 3.4 Ownership 13 15 Section 3.5 Governmental and Third Party Authorizations 14 15 Section 3.6 No Litigation 14 16 Section 3.7 Solvency 14 16 Section 3.8 Tax Matters 15 16 Section 3.9 No Brokers’ Fees 15 16 Section 3.10 Employee Benefit Matters 15 Section 3.11 Compliance with Laws 15 17 Section 3.11 Intellectual Property Matters 17 Section 3.12 Licensed Products 16 Regulatory Approval, Manufacturing and Marketing 19 Section 3.13 Regulatory Approval 16 Section 3.14 Counterparty Agreement 17 Section 3.15 First Agreement and Second License Agreement 19 Section 3.16 UCC Matters 20 Section 3.17 Margin Stock 20 Section 3.18 Investment Company Act 20 ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE PURCHASER Section 4.1 Organization 20 Section 4.2 No Conflicts 21 Section 4.3 Authorization 21 Section 4.4 Governmental and Third Party Authorizations 21 Section 4.5 No Litigation 21 Section 4.6 Access to Information 3.14 Profit Sharing Arrangements 22 Section 4.7 No Competitor 22 Section 4.8 3.15 UCC Matters 22 ARTICLE V COVENANTSSection 3.16 Set-off and Other Sources of Royalty Reduction 22 Section 3.17 Investment Company Status 22 Confidential Treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as “****”. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission.

Purchase and Sale of the Purchased Assets. Section 2.1 Purchase and Sale 10 Section 2.2 Purchase Price 11 Section 2.3 No Assumed Obligations 12 Section 2.4 Excluded Assets 12 ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE SELLER Section 3.1 Organization 12 Section 3.2 No Conflicts 12 Section 3.3 Authorization 13 Section 3.4 Ownership 13 Section 3.5 Governmental and Third Party Authorizations 14 Section 3.6 No Litigation 14 Section 3.7 Solvency 14 Section 3.8 Tax Matters 15 Section 3.9 No Brokers’ Fees 15 Section 3.10 Employee Benefit Matters 15 Section 3.11 Compliance with Laws 15 Section 3.12 Licensed Products 16 Section 3.13 Regulatory Approval 16 Section 3.14 Counterparty Agreement 17 Section 3.15 First Agreement and Second Agreement 19 Section 3.16 UCC Matters 20 Section 3.17 Margin Stock 20 Section 3.18 Investment Company Act 20 ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE PURCHASER Section 4.1 Organization 20 Section 4.2 No Conflicts 21 Section 4.3 Authorization 21 Section 4.4 Governmental and Third Party Authorizations 21 Section 4.5 No Litigation 21 Confidential Treatment Requested by Royalty Pharma plc Pursuant to 17 C.F.R. Section 200.83 Section 4.6 Access to Information 22 Section 4.7 No Competitor 22 Section 4.8 UCC Matters 22 ARTICLE V COVENANTS

Purchase and Sale of the Purchased Assets. Section 2.1 Purchase and Sale 10 of the Purchased Assets 6 Section 2.2 Purchase Price 11 Excluded Assets 6 Section 2.3 No Assumed Obligations 12 Liabilities 6 Section 2.4 Excluded Assets 12 Liabilities 6 Section 2.5 Purchase Price 8 Section 2.6 Closing 8 Section 2.7 Deliveries by Purchaser 8 Section 2.8 Deliveries by Seller 8 ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE SELLER Section 3.1 Organization 12 and Qualification 8 Section 3.2 No Conflicts 12 Purchased Assets 9 Section 3.3 Corporate Authorization 13 9 Section 3.4 Ownership 13 Consents and Approvals 9 Section 3.5 Governmental and Third Party Authorizations 14 Non-Contravention 9 Section 3.6 No Litigation 14 Binding Effect 9 Section 3.7 Solvency 14 Litigation and Claims 9 Section 3.8 Tax Matters 15 Property, Equipment and Other Purchased Assets 10 Section 3.9 No Brokers’ Fees 15 Intellectual Property 10 Section 3.10 Employee Benefit Matters 15 Certain Contracts 11 Section 3.11 Compliance with Laws 15 12 Section 3.12 Licensed Products 16 Governmental Authorizations 12 Section 3.13 Regulatory Approval 16 Collective Bargaining Agreements 12 Section 3.14 Counterparty Agreement 17 Transactions with Affiliates 12 Section 3.15 First Agreement and Second Agreement 19 Accuracy of Copies 13 Section 3.16 UCC Matters 20 Financial and Business Information 13 Section 3.17 Margin Stock 20 Environmental Matters 13 Section 3.18 Investment Company Act 20 Real Property 13 Section 3.19 Advisors’ Fees 13 ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE PURCHASER Section 4.1 Organization 20 Section 4.2 No Conflicts 21 Section 4.3 Authorization 21 Section 4.4 Governmental and Third Party Authorizations 21 Section 4.5 No Litigation 21 Section 4.6 Access to Information 22 Section 4.7 No Competitor 22 Section 4.8 UCC Matters 22 ARTICLE V COVENANTSIV

Purchase and Sale of the Purchased Assets. Section 2.1 Purchase and Sale 9 Section 2.2 Entitlement to Payments 10 Section 2.2 2.3 Purchase Price 11 10 Section 2.3 2.4 No Assumed Obligations 12 11 Section 2.4 2.5 Excluded Assets 12 11 ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE SELLER Section 3.1 Organization 12 11 Section 3.2 No Conflicts 12 Subsidiaries 11 Section 3.3 Seller Authorization 13 11 Section 3.4 Ownership 13 Section 3.5 Governmental and Third Party Authorizations 14 12 Section 3.5 Ownership 12 Section 3.6 Solvency 12 Section 3.7 No Litigation 14 Section 3.7 Solvency 14 13 Section 3.8 Tax Matters 15 Compliance with Laws 13 Section 3.9 No Brokers’ Fees 15 Conflicts 13 Section 3.10 Employee Benefit Matters 15 Intellectual Property Rights 14 Section 3.11 Compliance with Laws Regulatory Approval, Manufacturing and Marketing 15 Section 3.12 Licensed Products No Subordination 15 Section 3.13 Counterparty Agreements. 15 Section 3.14 Set-off and Other Sources of Royalty Reduction 16 Section 3.13 Regulatory Approval 16 Section 3.14 Counterparty Agreement 3.15 UCC Matters 17 Section 3.15 First Agreement and Second Agreement 19 Section 3.16 UCC Tax Matters 20 17 Section 3.17 Margin Stock 20 Section 3.18 Investment Company Act 20 17 ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE PURCHASER Section 4.1 Organization 20 Section 4.2 No Conflicts 21 Section 4.3 Authorization 21 Section 4.4 Governmental and Third Party Authorizations 21 Section 4.5 No Litigation 21 Section 4.6 Access to Information 22 Section 4.7 No Competitor 22 Section 4.8 UCC Matters 22 ARTICLE V COVENANTSIV

Purchase and Sale of the Purchased Assets. Section 2.1 Purchase and Sale 10 Section 2.2 Entitlement to Payments 11 Section 2.3 Purchase Price 11 Section 2.3 2.4 No Assumed Obligations 12 11 Section 2.4 2.5 Excluded Assets 12 ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE SELLER Section 3.1 Organization 12 Section 3.2 No Conflicts Seller Authorization 12 Section 3.3 Authorization 13 Section 3.4 Ownership 13 Section 3.5 Governmental and Third Party Authorizations 14 12 Section 3.4 Ownership 12 Section 3.5 Solvency 13 Section 3.6 No Litigation 14 13 Section 3.7 Solvency 14 Section 3.8 Tax Matters 15 Section 3.9 No Brokers’ Fees 15 Section 3.10 Employee Benefit Matters 15 Section 3.11 Compliance with Laws 15 13 Section 3.8 No Conflicts 14 Section 3.9 Broker’s Fees 14 Section 3.10 Intellectual Property Rights 14 Section 3.11 Regulatory Approval, Manufacturing and Marketing 16 Section 3.12 Licensed Products No Subordination 16 Section 3.13 Regulatory Approval License Documentation 16 Section 3.14 Counterparty Agreement 17 Set-off and Other Sources of Royalty Reduction 19 Section 3.15 First Agreement and Second Agreement UCC Matters 19 Section 3.16 UCC Tax Matters 20 19 Section 3.17 Margin Stock 20 Field of Use 19 Section 3.18 Investment Company Act Disclosure 20 ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE PURCHASER Section 4.1 Organization 20 Section 4.2 No Conflicts 21 Section 4.3 Authorization 21 Section 4.4 Governmental and Third Party Authorizations 21 Section 4.5 No Litigation 21 Section 4.6 Access to Information 22 Section 4.7 No Competitor 22 Section 4.8 UCC Matters 22 ARTICLE V COVENANTSIV

Purchase and Sale of the Purchased Assets. Section 2.1 Purchase and Sale Sale. 10 Section 2.2 Purchase Price 11 Section 2.3 No Assumed Obligations 12 11 Section 2.4 Excluded Assets 12 11 ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE SELLER Section 3.1 Organization 12 11 Section 3.2 No Conflicts Conflicts. 12 Section 3.3 Authorization 13 12 Section 3.4 Ownership 13 12 Section 3.5 Governmental and Third Party Authorizations 14 13 Section 3.6 No Litigation 14 13 Section 3.7 Solvency 14 13 Section 3.8 Tax Matters 15 14 Section 3.9 No Brokers’ Fees 15 14 Section 3.10 Employee Benefit Matters 15 Section 3.11 Compliance with Laws 15 14 Section 3.11 Intellectual Property Matters. 14 Section 3.12 Licensed Products Regulatory Approval, Manufacturing and Marketing. 16 Section 3.13 Regulatory Approval Counterparty License Agreement. 16 Section 3.14 Counterparty Agreement 17 UCC Matters 19 Section 3.15 First Agreement Set-off and Second Agreement Other Sources of Royalty Reduction 19 Section 3.16 UCC Matters 20 Section 3.17 Margin Stock 20 Section 3.18 Investment Company Act 20 19 ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE PURCHASER Section 4.1 Organization 20 Section 4.2 No Conflicts 21 Section 4.3 Authorization 21 Section 4.4 Governmental and Third Party Authorizations 21 Section 4.5 No Litigation 21 Section 4.6 Access to Information 22 Section 4.7 No Competitor 22 Section 4.8 UCC Matters 22 ARTICLE V COVENANTSIV

Purchase and Sale of the Purchased Assets. Section 2.1 Purchase and Sale 10 8 Section 2.2 Purchase Price 11 Payment of Investment Amount 8 Section 2.3 No Assumed Obligations 12 9 Section 2.4 Excluded Assets 12 9 Section 2.5 Seller Prepayment 9 ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE SELLER Section 3.1 Organization 12 9 Section 3.2 No Conflicts 12 9 Section 3.3 Authorization 13 10 Section 3.4 Ownership 13 10 Section 3.5 Governmental and Third Party Authorizations 14 10 Section 3.6 No Litigation 14 10 Section 3.7 Solvency 14 Tax Matters 11 Section 3.8 Tax Matters 15 Section 3.9 No Brokers’ Fees 15 11 Section 3.10 Employee Benefit Matters 15 Section 3.11 3.9 Compliance with Laws 15 11 Section 3.10 Intellectual Property Matters 11 Section 3.11 Regulatory Approval, Manufacturing and Marketing 12 Section 3.12 Licensed Products 16 Counterparty License Agreement. 13 Section 3.13 Regulatory Approval 16 UCC Matters 14 Section 3.14 Counterparty Agreement 17 Information 14 Section 3.15 First Agreement and Second Agreement 19 Insolvency; Material Adverse Change 14 Section 3.16 UCC Matters 20 Section 3.17 Margin Stock 20 Section 3.18 Investment Company Act 20 Set-off and Other Sources of Royalty Reduction 14 ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE PURCHASER Section 4.1 Organization 20 14 Section 4.2 No Conflicts 21 15 Section 4.3 Authorization 21 15 Section 4.4 Governmental and Third Party Authorizations 21 15 Section 4.5 No Litigation 21 15 Section 4.6 Access to Information 22 15 Section 4.7 No Competitor 22 Section 4.8 UCC Matters 22 Funds Available 15 ARTICLE V COVENANTS

Purchase and Sale of the Purchased Assets. Section 2.1 Purchase and Sale Sale. 10 Section 2.2 Purchase Price 11 Section 2.3 [*****] 12 Section 2.4 No Assumed Obligations 12 Section 2.4 2.5 Excluded Assets 12 Section 2.6 Payment Default 13 ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE SELLER Section 3.1 Organization 12 13 Section 3.2 No Conflicts 12 Conflicts. 13 Section 3.3 Authorization 13 14 Section 3.4 Ownership 13 14 Section 3.5 Governmental and Third Party Authorizations 14 15 Section 3.6 No Litigation 14 15 Section 3.7 Solvency 14 15 Section 3.8 Tax Matters 15 Section 3.9 No Brokers’ Fees 15 16 Section 3.10 Employee Benefit Matters 15 Section 3.11 3.9 Compliance with Laws 15 16 Section 3.10 Intellectual Property Matters. 16 Section 3.11 Regulatory Approval, Manufacturing and Marketing. 17 Section 3.12 Licensed Products 16 Counterparty License Agreement. 17 Section 3.13 Regulatory Approval 16 UCC Matters 19 Section 3.14 Counterparty Agreement 17 Set-off and Other Sources of Royalty Reduction 20 Section 3.15 First Agreement and Second Agreement 19 Section 3.16 UCC Matters 20 Section 3.17 Margin Stock 20 Section 3.18 Investment Company Act Competing Products 20 ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE PURCHASER Section 4.1 Organization 20 Section 4.2 No Conflicts 21 20 Section 4.3 Authorization 21 Section 4.4 Governmental and Third Party Authorizations 21 Section 4.5 No Litigation 21 Table of Contents (Continued) Page Section 4.6 Access to Information 22 21 Section 4.7 No Competitor 22 Section 4.8 UCC Matters 22 Funds Available 21 ARTICLE V COVENANTSV

Purchase and Sale of the Purchased Assets. Section 2.1 Purchase and Sale 10 Section 2.2 Purchase Price 11 12 Section 2.3 No Assumed Obligations 12 Section 2.4 Excluded Assets 12 Section 2.5 Power of Attorney 13 ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE SELLER Section 3.1 Organization 12 13 Section 3.2 No Conflicts 12 14 Section 3.3 Authorization 13 14 Section 3.4 Ownership 13 15 Section 3.5 Governmental and Third Party Authorizations 14 15 Section 3.6 No Litigation 14 15 Section 3.7 Solvency 14 16 Section 3.8 Tax Matters 15 16 Section 3.9 No Brokers’ Fees 15 16 Section 3.10 Employee Benefit Matters 15 Section 3.11 Compliance with Laws 15 16 Section 3.11 Intellectual Property Matters 16 Section 3.12 Licensed Products 16 Regulatory Approval, Manufacturing and Marketing 18 Section 3.13 Regulatory Approval 16 Section 3.14 Counterparty Agreement 17 Section 3.15 First Agreement and Second License Agreement 19 Section 3.16 3.14 Profit Sharing Arrangements 21 Section 3.15 UCC Matters 20 21 Section 3.16 Set-off and Other Sources of Royalty Reduction 21 Section 3.17 Margin Stock 20 Section 3.18 Investment Company Act 20 ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE PURCHASER Section 4.1 Organization 20 Section 4.2 No Conflicts 21 Section 4.3 Authorization 21 Section 4.4 Governmental and Third Party Authorizations 21 Section 4.5 No Litigation 21 Section 4.6 Access to Information 22 Section 4.7 No Competitor 22 Section 4.8 UCC Matters 22 ARTICLE V COVENANTSStatus 22